| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.3 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |